Michelle Crank, MD
Allergy & Immunology · Wheaton, MDNPI 1861601650
Payments from drug & device makers
Across 479 payments — averaging $39.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$8K
- GSK$1K
- AstraZeneca$983
- Octapharma USA, Inc.$930
- Biocryst US Sales Co., LLC$804
- Takeda Pharmaceuticals U.S.A., Inc.$759
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 2 | $8,000 |
| GSK | 51 | $1,071 |
| AstraZeneca | 52 | $983 |
| Octapharma USA, Inc. | 18 | $930 |
| Biocryst US Sales Co., LLC | 44 | $804 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $759 |
| CSL Behring | 29 | $667 |
| Pfizer | 38 | $622 |
| Novartis | 23 | $542 |
| Regeneron Healthcare Solutions, Inc. | 22 | $541 |
| Sanofi | 15 | $479 |
| Amgen | 19 | $460 |
| Optinose US, Inc. | 18 | $402 |
| Grifols USA, LLC | 17 | $388 |
| Pharming Healthcare, Inc. | 15 | $359 |
| Genentech USA, Inc. | 13 | $304 |
| Kaleo, Inc. | 11 | $231 |
| Ionis Pharmaceuticals, Inc. | 6 | $139 |
| Aimmune Therapeutics, Inc. | 7 | $131 |
| Teva Pharmaceuticals USA, Inc. | 7 | $123 |
| Blueprint Medicines Corporation | 4 | $114 |
| Alk-abello, Inc | 5 | $98 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $98 |
| Boehringer Ingelheim | 5 | $85 |
| Seqirus USA Inc | 4 | $82 |
| AbbVie | 3 | $76 |
| ADMA Biomanufacturing LLC | 3 | $66 |
| Shire North American Group Inc | 2 | $41 |
| Phadia US Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| Invivyd Inc | 1 | $24 |
| Organon | 1 | $24 |
| Merck | 1 | $23 |
| LEO Pharma Inc. | 1 | $17 |
| GC Biopharma USA, Inc. | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
How this compares
$18,794 in reported general payments places this provider in the 85th percentile of 105 allergy & immunology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Wheaton
- Mark ScarupaWheaton$1.2M
- Athena EconomidesWheaton$11K
- Daniel RosloffWheaton$10K
- Martha WhiteWheaton$4K
- Antoine AzarBaltimore$990K
- Melanie DispenzaBaltimore$866K
- Gordon RaphaelBethesda$752K
- Matthew MardineyBel Air$643K
- Sudhir SekhsariaRockville$565K
- Manav SinglaWhite Marsh$506K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.